<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245202</url>
  </required_header>
  <id_info>
    <org_study_id>17-TIP-012</org_study_id>
    <nct_id>NCT04245202</nct_id>
  </id_info>
  <brief_title>Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Bronchiolitis</brief_title>
  <official_title>Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Moderate and Severe Bronchiolitis; a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to compare the efficacy of two different oxygenation methods on decrease&#xD;
      respiratory rate, heart rate, and clinical respiratory score in children with moderate to&#xD;
      severe bronchiolitis requiring oxygen therapy.&#xD;
&#xD;
        1. Standard face mask oxygen therapy (St-FMOT)&#xD;
&#xD;
        2. High-flow nasal cannula oxygen therapy (HFNCOT)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchiolitis is the most common cause of hospitalization for children under one year of age&#xD;
      and, caused by respiratory viruses. Although several medications and interventions studied&#xD;
      for bronchiolitis treatment, hydration and oxygenation are the main treatments. High-flow&#xD;
      nasal cannula oxygen therapy (HFNCOT) has been widely used to provide respiratory support in&#xD;
      children with acute respiratory diseases.&#xD;
&#xD;
      Patients had earlier improvement with HFNCOT to decrease the respiratory rate and respiratory&#xD;
      effort than patients with standard low-flow oxygen therapy (SOT).&#xD;
&#xD;
      HFNCOT therapy reduced more effective in heart rate, respiratory effort, and length of&#xD;
      supportive oxygen treatment (LOOT) compared with SOT. However, the length of hospital stay&#xD;
      (LOS) and feeding ability had better consequences in patients with moderate and severe&#xD;
      bronchiolitis treated with HFNCOT.&#xD;
&#xD;
      Another published study shows that in infants with acute bronchiolitis, which required oxygen&#xD;
      therapy, there was no significant difference between therapy groups in terms of LOOT, LOS,&#xD;
      and admission to the intensive care unit (ICU). HFNCOT was more efficient than SOT and&#xD;
      reduced the rate of intubation/invasive ventilation in severe bronchiolitis management.&#xD;
      Despite these beneficial effects of HFNCOT, it was not recommended by international&#xD;
      guidelines yet. However, well designed, prospective randomized controlled trials are still&#xD;
      needed to use this therapy in the wards.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 14, 2017</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">March 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Taken to Reach the Normal Range for Heart Rate (Per-protocol Analysis)</measure>
    <time_frame>through study completion, an average of 96 hours</time_frame>
    <description>The time that heart rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time Taken to Reach the Normal Range for Respiratory Rate (Per-protocol Analysis)</measure>
    <time_frame>through study completion, an average of 96 hours</time_frame>
    <description>The time that the respiratory rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time Taken to Regress A Lower Clinical Respiratory Score (Per-protocol Analysis)</measure>
    <time_frame>through study completion, an average of 96 hours</time_frame>
    <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). The time that takes from severe bronchiolitis (9-12 points) to moderate bronchiolitis (5-8 points) or from moderate bronchiolitis (5-8 points) to mild bronchiolitis (0-4 points) between the groups. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate (Intention-to-treat Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate (Per-protocol Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate (Intention-to-treat Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate (Per-protocol Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Respiratory Score (Intention-to-treat Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Unabbreviated scale title: Clinical Respiratory Score (Intention-to-treat analysis) Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups.&#xD;
This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing.&#xD;
The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Respiratory Score (Per-protocol Analysis)</measure>
    <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
    <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups. This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing. The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Requirement (Intention-to-treat Analysis)</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The total duration of oxygen therapy (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Requirement (Per-protocol Analysis)</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The total duration of oxygen therapy (Per-protocol analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay (Intention-to-treat Analysis)</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The time from randomization to the patient's discharge (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay (Per-protocol Analysis)</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The time from randomization to the patient's discharge (Per-protocol analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Failure at 4 Hours (Intention-to-treat Analysis)</measure>
    <time_frame>4 hours</time_frame>
    <description>The number of treatment failures at 4 hours in each study arm (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Intensive Care Unit Admission (Intention-to-treat Analysis).</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The number of participants admitted to the intensive care unit for invasive mechanical ventilation (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events of Therapy (Intention-to-treat Analysis)</measure>
    <time_frame>through study completion, an average of 168 hours</time_frame>
    <description>The number of participants with any adverse events in therapy groups (Intention-to-treat analysis).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Acute Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Active Comparator: HFNCOT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Set between 2 to 25 l/min, adjusted to obtain peripheral oxygen saturation &gt;92%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Comparator: St-FMOT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To obtain oxygen saturation &gt;92%</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFNCOT</intervention_name>
    <description>The patient will receive a high flow nasal of humidified oxygen, set between 2 to 25 l/min. The inspired fraction of oxygen (FiO2) will be adjusted to obtain the oxygen saturation &gt;92%.</description>
    <arm_group_label>Active Comparator: HFNCOT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>St-FMOT</intervention_name>
    <description>The inspired fraction of oxygen (FiO2) will be adjusted to obtain the oxygen saturation &gt;92%.</description>
    <arm_group_label>Active Comparator: St-FMOT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children aged between 1-24 months applied with moderate and severe bronchiolitis&#xD;
             requiring supplemental oxygen were eligible for the study.&#xD;
&#xD;
          -  The severity of bronchiolitis was assessed according to the clinical respiratory score&#xD;
             (CRS) of Liu et al. (5). The patients with CRS ≥5 were included.&#xD;
&#xD;
          -  Peripheral oxyhemoglobin saturation is &lt; 92%.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Children admitted to the ICU for urgent invasive mechanical ventilation;&#xD;
&#xD;
          -  those who received standard oxygen therapy (SOT) or HFNCOT at other facilities before&#xD;
             arrival;&#xD;
&#xD;
          -  those with an underlying medical condition (such as congenital heart disease, chronic&#xD;
             lung disease, neuromuscular disease, metabolic disease, or immunocompromised);&#xD;
&#xD;
          -  those who had a craniofacial malformation, an upper airway obstruction, pneumothorax,&#xD;
             or nasal trauma, and missing parental consent or a refused permission of the&#xD;
             participant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aykut Eşki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ege University Medical Study</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ege University Medical Faculty</name>
      <address>
        <city>Izmir</city>
        <state>Select A State</state>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA, Dalziel SR, Schibler A. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med. 2018 Mar 22;378(12):1121-1131. doi: 10.1056/NEJMoa1714855.</citation>
    <PMID>29562151</PMID>
  </results_reference>
  <results_reference>
    <citation>Franklin D, Dalziel S, Schlapbach LJ, Babl FE, Oakley E, Craig SS, Furyk JS, Neutze J, Sinn K, Whitty JA, Gibbons K, Fraser J, Schibler A; PARIS and PREDICT. Early high flow nasal cannula therapy in bronchiolitis, a prospective randomised control trial (protocol): A Paediatric Acute Respiratory Intervention Study (PARIS). BMC Pediatr. 2015 Nov 14;15:183. doi: 10.1186/s12887-015-0501-x.</citation>
    <PMID>26572729</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu G, Fan C, Wu H. High-flow nasal cannula therapies for respiratory management in pediatric patients. Minerva Pediatr. 2018 Oct;70(5):488-492. doi: 10.23736/S0026-4946.17.04781-8. Epub 2017 Mar 27. Review.</citation>
    <PMID>28353318</PMID>
  </results_reference>
  <results_reference>
    <citation>Pham TM, O'Malley L, Mayfield S, Martin S, Schibler A. The effect of high flow nasal cannula therapy on the work of breathing in infants with bronchiolitis. Pediatr Pulmonol. 2015 Jul;50(7):713-20. doi: 10.1002/ppul.23060. Epub 2014 May 21.</citation>
    <PMID>24846750</PMID>
  </results_reference>
  <results_reference>
    <citation>Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr. 2013 Dec;172(12):1649-56. doi: 10.1007/s00431-013-2094-4. Epub 2013 Jul 31.</citation>
    <PMID>23900520</PMID>
  </results_reference>
  <results_reference>
    <citation>Milési C, Pierre AF, Deho A, Pouyau R, Liet JM, Guillot C, Guilbert AS, Rambaud J, Millet A, Afanetti M, Guichoux J, Genuini M, Mansir T, Bergounioux J, Michel F, Marcoux MO, Baleine J, Durand S, Durand P, Dauger S, Javouhey E, Leteurtre S, Brissaud O, Renolleau S, Portefaix A, Douillard A, Cambonie G; GFRUP Respiratory Study Group. A multicenter randomized controlled trial of a 3-L/kg/min versus 2-L/kg/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2). Intensive Care Med. 2018 Nov;44(11):1870-1878. doi: 10.1007/s00134-018-5343-1. Epub 2018 Oct 21.</citation>
    <PMID>30343318</PMID>
  </results_reference>
  <results_reference>
    <citation>Mace AO, Gibbons J, Schultz A, Knight G, Martin AC. Humidified high-flow nasal cannula oxygen for bronchiolitis: should we go with the flow? Arch Dis Child. 2018 Mar;103(3):303. doi: 10.1136/archdischild-2017-313950. Epub 2017 Sep 13.</citation>
    <PMID>28903952</PMID>
  </results_reference>
  <results_reference>
    <citation>Testa G, Iodice F, Ricci Z, Vitale V, De Razza F, Haiberger R, Iacoella C, Conti G, Cogo P. Comparative evaluation of high-flow nasal cannula and conventional oxygen therapy in paediatric cardiac surgical patients: a randomized controlled trial. Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):456-61. doi: 10.1093/icvts/ivu171. Epub 2014 Jun 8.</citation>
    <PMID>24912486</PMID>
  </results_reference>
  <results_reference>
    <citation>Milési C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, Cambonie G. High-flow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care. 2014 Sep 30;4:29. doi: 10.1186/s13613-014-0029-5. eCollection 2014. Review.</citation>
    <PMID>25593745</PMID>
  </results_reference>
  <results_reference>
    <citation>Schibler A, Franklin D. Respiratory support for children in the emergency department. J Paediatr Child Health. 2016 Feb;52(2):192-6. doi: 10.1111/jpc.13078. Review.</citation>
    <PMID>27062623</PMID>
  </results_reference>
  <results_reference>
    <citation>Da Dalt L, Bressan S, Martinolli F, Perilongo G, Baraldi E. Treatment of bronchiolitis: state of the art. Early Hum Dev. 2013 Jun;89 Suppl 1:S31-6. doi: 10.1016/S0378-3782(13)70011-2. Review.</citation>
    <PMID>23809346</PMID>
  </results_reference>
  <results_reference>
    <citation>Beggs S, Wong ZH, Kaul S, Ogden KJ, Walters JA. High-flow nasal cannula therapy for infants with bronchiolitis. Cochrane Database Syst Rev. 2014 Jan 20;(1):CD009609. doi: 10.1002/14651858.CD009609.pub2. Review.</citation>
    <PMID>24442856</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <results_first_submitted>May 8, 2020</results_first_submitted>
  <results_first_submitted_qc>February 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 16, 2021</results_first_posted>
  <last_update_submitted>February 14, 2021</last_update_submitted>
  <last_update_submitted_qc>February 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ege University</investigator_affiliation>
    <investigator_full_name>Aykut Eşki</investigator_full_name>
    <investigator_title>Medical Doctor, Pediatric Pulmonology</investigator_title>
  </responsible_party>
  <keyword>Acute Bronchiolitis</keyword>
  <keyword>High Flow Nasal Cannula</keyword>
  <keyword>Standard Face Mask</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 10, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/02/NCT04245202/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From March 14, 2017, through March 10, 2020, 5643 patients were presented to the emergency department and pediatric pulmonology unit of Ege University Medical Faculty. Four hundred seventy-two children were eligible for the study, with 134 missing opportunities to enroll, and 251 parents declined consent. We randomly assigned 87 children to Standard face mask oxygen therapy and High-Flow nasal cannula therapy.</recruitment_details>
      <pre_assignment_details>No patients were excluded from the study after participant enrollment.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>St-FMOT</title>
          <description>Children in the standard-therapy group received supplemental oxygen via a simple face mask, a range of 6-10 L/min, to maintain oxygen saturation level between 92-98%. Those who sustained the oxygen saturation &gt;92% in the ambient oxygen concentration were weaned off Standard face mask oxygen therapy.</description>
        </group>
        <group group_id="P2">
          <title>HFNCOT</title>
          <description>Children in the high-flow group received heated and humidified high-flow oxygen at a rate of 2 L*kg/min (maximum 25 L/min), using an age-appropriate Optiflow Junior cannula and Airvo 2 high-flow system (Fisher and Paykel Healthcare). The initial fraction of inspired oxygen (FiO2) was set at 40%. The starting flow rate continued for a minimum of 4 hours. According to the patients' clinical response, the flow rate was decreased by 0.5 L*kg/min per hour. The FiO2 was adjusted to obtain the oxygen saturation levels between 92-98%. When the flow rate was at 0.5 L*kg/min, and the FiO2 was equal to the ambient oxygen concentration, High-Flow nasal cannula oxygen therapy was stopped.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48">After getting consent.</participants>
                <participants group_id="P2" count="39">After getting consent</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline demographic characteristics of participants according to allocation (Intention-to-treat analysis)</population>
      <group_list>
        <group group_id="B1">
          <title>St-FMOT</title>
          <description>Children who received standard face mask oxygen treatment</description>
        </group>
        <group group_id="B2">
          <title>HFNCOT</title>
          <description>Children who received high flow nasal cannula oxygen treatment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.5" lower_limit="3.6" upper_limit="11.0"/>
                    <measurement group_id="B2" value="6.0" lower_limit="3.0" upper_limit="12.0"/>
                    <measurement group_id="B3" value="6.0" lower_limit="3.5" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age at birth</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Prematurity (&lt; 37 weeks)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Term infant (&gt; 36 weeks)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight at the admission (kg)</title>
          <units>kilogram</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.4" lower_limit="6.0" upper_limit="9.5"/>
                    <measurement group_id="B2" value="8.0" lower_limit="5.1" upper_limit="10.0"/>
                    <measurement group_id="B3" value="8.0" lower_limit="6.0" upper_limit="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline heart rate</title>
          <units>beat per minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174.0" lower_limit="156.2" upper_limit="186.5"/>
                    <measurement group_id="B2" value="170.0" lower_limit="157.0" upper_limit="188.0"/>
                    <measurement group_id="B3" value="173.0" lower_limit="157.0" upper_limit="188.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline respiratory rate</title>
          <units>Breaths per minute</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.5" lower_limit="60.0" upper_limit="70.0"/>
                    <measurement group_id="B2" value="66.0" lower_limit="60.0" upper_limit="72.0"/>
                    <measurement group_id="B3" value="66.0" lower_limit="60.0" upper_limit="70.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Oxygen Saturation</title>
          <units>percentage of saturated oxygen</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88.0" lower_limit="86.2" upper_limit="89.0"/>
                    <measurement group_id="B2" value="87.0" lower_limit="84.0" upper_limit="88.0"/>
                    <measurement group_id="B3" value="88.0" lower_limit="86.0" upper_limit="88.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline clinical respiratory score</title>
          <description>Unabbreviated scale title: Clinical Respiratory Score, categorizing as severe bronchiolitis (9-12 points), moderate bronchiolitis (5-8 points), and mild bronchiolitis (0-4 points). Higher scores mean a worse outcome. This score involves respiratory rate, retraction, dyspnea/consciousness status, and wheezing. Each variable ranges from 0 to 3 points.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.0" lower_limit="7.0" upper_limit="10.2"/>
                    <measurement group_id="B2" value="9.5" lower_limit="8.7" upper_limit="11.0"/>
                    <measurement group_id="B3" value="9.0" lower_limit="8.0" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Severity of clinical respiratory score</title>
          <description>Unabbreviated scale title: Clinical Respiratory Score, categorizing as severe bronchiolitis (9-12 points), moderate bronchiolitis (5-8 points), and mild bronchiolitis (0-4 points). Higher scores mean a worse outcome. This score involves respiratory rate, retraction, dyspnea/consciousness status, and wheezing. Each variable ranges from 0 to 3 points.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Moderate</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Season admitted</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Winter</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Autumn</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Spring</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Summer</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of detected virus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>No virus</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1 virus</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2 viruses</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Virus detected</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>RSV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HRV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>FLUA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>PIV3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HBoV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>hMPV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>hCoV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+HRV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+PIV2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+PIV3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+FLUA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+hCOV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HBoV+hCOV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>hMPV+hCOV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>hCOV+hAV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>RSV+HBoV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HRV+FLUA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HRV+HBoV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No virus</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Taken to Reach the Normal Range for Heart Rate (Per-protocol Analysis)</title>
        <description>The time that heart rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
        <time_frame>through study completion, an average of 96 hours</time_frame>
        <population>The population of the per-protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Time Taken to Reach the Normal Range for Heart Rate (Per-protocol Analysis)</title>
          <description>The time that heart rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
          <population>The population of the per-protocol.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="2" upper_limit="24"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time Taken to Reach the Normal Range for Respiratory Rate (Per-protocol Analysis)</title>
        <description>The time that the respiratory rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
        <time_frame>through study completion, an average of 96 hours</time_frame>
        <population>The population of the per-protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Time Taken to Reach the Normal Range for Respiratory Rate (Per-protocol Analysis)</title>
          <description>The time that the respiratory rate takes into the normal range for age between the groups (Per-protocol analysis).</description>
          <population>The population of the per-protocol.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24" lower_limit="4" upper_limit="48"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time Taken to Regress A Lower Clinical Respiratory Score (Per-protocol Analysis)</title>
        <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). The time that takes from severe bronchiolitis (9-12 points) to moderate bronchiolitis (5-8 points) or from moderate bronchiolitis (5-8 points) to mild bronchiolitis (0-4 points) between the groups. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
        <time_frame>through study completion, an average of 96 hours</time_frame>
        <population>The population of the per-protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Time Taken to Regress A Lower Clinical Respiratory Score (Per-protocol Analysis)</title>
          <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). The time that takes from severe bronchiolitis (9-12 points) to moderate bronchiolitis (5-8 points) or from moderate bronchiolitis (5-8 points) to mild bronchiolitis (0-4 points) between the groups. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
          <population>The population of the per-protocol.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="2" upper_limit="24"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate (Intention-to-treat Analysis)</title>
        <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate (Intention-to-treat Analysis)</title>
          <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis</population>
          <units>beats per minute</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172.90" lower_limit="167.68" upper_limit="178.64"/>
                    <measurement group_id="O2" value="171.05" lower_limit="165.26" upper_limit="176.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="166.21" lower_limit="160.99" upper_limit="171.43"/>
                    <measurement group_id="O2" value="151.28" lower_limit="145.49" upper_limit="157.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164.00" lower_limit="158.78" upper_limit="169.22"/>
                    <measurement group_id="O2" value="146.59" lower_limit="140.80" upper_limit="152.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159.65" lower_limit="154.43" upper_limit="164.86"/>
                    <measurement group_id="O2" value="138.05" lower_limit="132.26" upper_limit="143.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="153.43" lower_limit="147.88" upper_limit="158.98"/>
                    <measurement group_id="O2" value="132.47" lower_limit="126.64" upper_limit="138.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.96" lower_limit="137.25" upper_limit="148.67"/>
                    <measurement group_id="O2" value="132.56" lower_limit="126.71" upper_limit="138.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.21" lower_limit="133.42" upper_limit="145.00"/>
                    <measurement group_id="O2" value="128.48" lower_limit="122.63" upper_limit="134.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135.99" lower_limit="130.09" upper_limit="141.90"/>
                    <measurement group_id="O2" value="124.96" lower_limit="118.92" upper_limit="130.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133.61" lower_limit="127.60" upper_limit="139.62"/>
                    <measurement group_id="O2" value="119.47" lower_limit="113.15" upper_limit="125.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>The p-Value of the interaction between time and groups was given. In all analyses, p values &lt;0·05 were considered being statistically significant.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-12.29</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>5.72</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-23.53</ci_lower_limit>
            <ci_upper_limit>-1.05</ci_upper_limit>
            <estimate_desc>Treatment difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate (Per-protocol Analysis)</title>
        <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Per-protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate (Per-protocol Analysis)</title>
          <description>Any differences in the time any recorded changes in heart rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
          <population>Per-protocol analysis</population>
          <units>beats per minute</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.03" lower_limit="164.22" upper_limit="173.83"/>
                    <measurement group_id="O2" value="170.37" lower_limit="165.56" upper_limit="175.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="160.76" lower_limit="155.96" upper_limit="165.57"/>
                    <measurement group_id="O2" value="150.37" lower_limit="145.56" upper_limit="155.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="157.58" lower_limit="152.77" upper_limit="162.38"/>
                    <measurement group_id="O2" value="145.39" lower_limit="140.59" upper_limit="150.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150.66" lower_limit="145.85" upper_limit="155.46"/>
                    <measurement group_id="O2" value="136.42" lower_limit="131.62" upper_limit="141.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147.08" lower_limit="142.27" upper_limit="151.88"/>
                    <measurement group_id="O2" value="131.32" lower_limit="126.51" upper_limit="136.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138.45" lower_limit="133.64" upper_limit="143.25"/>
                    <measurement group_id="O2" value="131.74" lower_limit="126.93" upper_limit="136.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135.97" lower_limit="131.17" upper_limit="140.78"/>
                    <measurement group_id="O2" value="127.89" lower_limit="123.09" upper_limit="132.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136.43" lower_limit="131.54" upper_limit="141.31"/>
                    <measurement group_id="O2" value="124.57" lower_limit="119.60" upper_limit="129.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133.85" lower_limit="128.90" upper_limit="138.81"/>
                    <measurement group_id="O2" value="122.53" lower_limit="117.30" upper_limit="127.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The p-Value of the interaction between time and groups was given. In all analyses, p values &lt;0·05 were considered being statistically significant.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-12.66</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>4.77</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-22.05</ci_lower_limit>
            <ci_upper_limit>-3.28</ci_upper_limit>
            <estimate_desc>Treatment difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate (Intention-to-treat Analysis)</title>
        <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate (Intention-to-treat Analysis)</title>
          <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis.</population>
          <units>Breaths per minute</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.08" lower_limit="62.77" upper_limit="67.39"/>
                    <measurement group_id="O2" value="66.71" lower_limit="64.15" upper_limit="69.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.20" lower_limit="57.89" upper_limit="62.51"/>
                    <measurement group_id="O2" value="56.84" lower_limit="54.28" upper_limit="59.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.45" lower_limit="55.14" upper_limit="59.76"/>
                    <measurement group_id="O2" value="51.10" lower_limit="48.54" upper_limit="53.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.54" lower_limit="53.23" upper_limit="57.85"/>
                    <measurement group_id="O2" value="46.56" lower_limit="44.00" upper_limit="49.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.06" lower_limit="48.63" upper_limit="53.48"/>
                    <measurement group_id="O2" value="44.15" lower_limit="41.57" upper_limit="46.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.54" lower_limit="44.05" upper_limit="49.03"/>
                    <measurement group_id="O2" value="40.82" lower_limit="38.24" upper_limit="43.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.89" lower_limit="39.36" upper_limit="44.42"/>
                    <measurement group_id="O2" value="39.32" lower_limit="36.74" upper_limit="41.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.24" lower_limit="36.65" upper_limit="41.82"/>
                    <measurement group_id="O2" value="36.70" lower_limit="34.07" upper_limit="39.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.75" lower_limit="35.12" upper_limit="40.38"/>
                    <measurement group_id="O2" value="35.47" lower_limit="32.79" upper_limit="38.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>The p-Value of the interaction between time and groups was given. In all analysis, p values &lt;0.05 were considered being statistically significant.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-3.91</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.43</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.68</ci_lower_limit>
            <ci_upper_limit>0.86</ci_upper_limit>
            <estimate_desc>Treatment difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Rate (Per-protocol Analysis)</title>
        <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Per-protocol analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Rate (Per-protocol Analysis)</title>
          <description>Any differences in the time any recorded changes in respiratory rate from randomization to the patients' discharge within the groups and between the groups (Per-protocol analysis).</description>
          <population>Per-protocol analysis.</population>
          <units>breaths per minute</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.52" lower_limit="63.15" upper_limit="67.89"/>
                    <measurement group_id="O2" value="66.68" lower_limit="64.31" upper_limit="69.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.50" lower_limit="57.12" upper_limit="61.87"/>
                    <measurement group_id="O2" value="56.60" lower_limit="54.23" upper_limit="58.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.34" lower_limit="52.96" upper_limit="57.71"/>
                    <measurement group_id="O2" value="50.65" lower_limit="48.28" upper_limit="53.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.81" lower_limit="49.44" upper_limit="54.18"/>
                    <measurement group_id="O2" value="46.00" lower_limit="43.62" upper_limit="48.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.13" lower_limit="45.75" upper_limit="50.50"/>
                    <measurement group_id="O2" value="43.71" lower_limit="41.33" upper_limit="46.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.23" lower_limit="41.86" upper_limit="46.60"/>
                    <measurement group_id="O2" value="40.47" lower_limit="38.10" upper_limit="42.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.07" lower_limit="37.70" upper_limit="42.45"/>
                    <measurement group_id="O2" value="39.05" lower_limit="36.68" upper_limit="41.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.82" lower_limit="35.42" upper_limit="40.22"/>
                    <measurement group_id="O2" value="36.51" lower_limit="34.09" upper_limit="38.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.63" lower_limit="34.20" upper_limit="39.06"/>
                    <measurement group_id="O2" value="35.37" lower_limit="32.85" upper_limit="37.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The p-Value of the interaction between time and groups was given. In all analysis, p values &lt;0.05 were considered being statistically significant.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-2.41</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>2.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.62</ci_lower_limit>
            <ci_upper_limit>1.78</ci_upper_limit>
            <estimate_desc>Treatment difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Respiratory Score (Intention-to-treat Analysis)</title>
        <description>Unabbreviated scale title: Clinical Respiratory Score (Intention-to-treat analysis) Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups.&#xD;
This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing.&#xD;
The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Respiratory Score (Intention-to-treat Analysis)</title>
          <description>Unabbreviated scale title: Clinical Respiratory Score (Intention-to-treat analysis) Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups.&#xD;
This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing.&#xD;
The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
          <population>Intention to treat analysis.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" lower_limit="7.0" upper_limit="10.0"/>
                    <measurement group_id="O2" value="10.0" lower_limit="9.0" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" lower_limit="6.5" upper_limit="10.0"/>
                    <measurement group_id="O2" value="7.0" lower_limit="7.0" upper_limit="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" lower_limit="6.0" upper_limit="10.0"/>
                    <measurement group_id="O2" value="6.0" lower_limit="5.0" upper_limit="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" lower_limit="6.0" upper_limit="9.5"/>
                    <measurement group_id="O2" value="5.0" lower_limit="4.0" upper_limit="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="4.0" upper_limit="7.0"/>
                    <measurement group_id="O2" value="5.0" lower_limit="3.0" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="3.0" upper_limit="6.0"/>
                    <measurement group_id="O2" value="4.0" lower_limit="2.0" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2.0" upper_limit="5.0"/>
                    <measurement group_id="O2" value="2.0" lower_limit="1.0" upper_limit="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" lower_limit="1.0" upper_limit="4.0"/>
                    <measurement group_id="O2" value="2.0" lower_limit="1.0" upper_limit="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" lower_limit="0.0" upper_limit="3.0"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0.0" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <p_value_desc>The p-Value of the interaction between time and groups was given. In all analysis, p values &lt;0.05 were considered being statistically significant.</p_value_desc>
            <method>Brunner-Langer Method</method>
            <param_type>Relative treatment effect difference</param_type>
            <param_value>-0.07</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Relative Treatment Effect Difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Respiratory Score (Per-protocol Analysis)</title>
        <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups. This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing. The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
        <time_frame>Baseline, 1,2,4,12,24,48,72 and 96 hours</time_frame>
        <population>Per-protocol analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Respiratory Score (Per-protocol Analysis)</title>
          <description>Unabbreviated scale title: Clinical Respiratory Score (Per-protocol analysis). Any differences in the time any recorded changes in the clinical respiratory score from randomization to the patients' discharge within the groups and between the groups. This clinical respiratory score includes respiratory rate, retraction, dyspnea/consciousness status, and wheezing. The severity of parameters is scored 0 to 3 points, and the patients with a clinical respiratory score of 0-4 points were defined as mild, moderate (5-8 points), and severe (9-12 point) bronchiolitis. Higher scores mean a worse outcome. The score ranges from 0-12.</description>
          <population>Per-protocol analysis.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" lower_limit="7.0" upper_limit="10.2"/>
                    <measurement group_id="O2" value="9.5" lower_limit="8.7" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" lower_limit="6.0" upper_limit="9.0"/>
                    <measurement group_id="O2" value="7.0" lower_limit="7.0" upper_limit="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" lower_limit="5.7" upper_limit="8.0"/>
                    <measurement group_id="O2" value="6.0" lower_limit="5.0" upper_limit="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" lower_limit="5.0" upper_limit="8.0"/>
                    <measurement group_id="O2" value="5.0" lower_limit="4.0" upper_limit="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="4.0" upper_limit="7.0"/>
                    <measurement group_id="O2" value="5.0" lower_limit="3.0" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="2.7" upper_limit="6.0"/>
                    <measurement group_id="O2" value="4.0" lower_limit="2.0" upper_limit="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2.0" upper_limit="5.0"/>
                    <measurement group_id="O2" value="2.0" lower_limit="1.0" upper_limit="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>72 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" lower_limit="1.0" upper_limit="4.0"/>
                    <measurement group_id="O2" value="2.0" lower_limit="1.0" upper_limit="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>96 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" lower_limit="0.0" upper_limit="3.0"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0.0" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>The p-Value of the interaction between time and groups was given. In all analysis, p values &lt;0.05 were considered being statistically significant.</p_value_desc>
            <method>Brunner-Langer Method</method>
            <param_type>Relative treatment effect difference</param_type>
            <param_value>-0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Relative Treatment Effect Difference= High-Flow Nasal Cannula Oxygen Therapy (96-0 h) - Standard Face Mask Oxygen Therapy (96-0 h) (based on least-square means)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Requirement (Intention-to-treat Analysis)</title>
        <description>The total duration of oxygen therapy (Intention-to-treat analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Intention to treat analysis</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Requirement (Intention-to-treat Analysis)</title>
          <description>The total duration of oxygen therapy (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.5" lower_limit="14.0" upper_limit="45.7"/>
                    <measurement group_id="O2" value="19.0" lower_limit="4.0" upper_limit="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxygen Requirement (Per-protocol Analysis)</title>
        <description>The total duration of oxygen therapy (Per-protocol analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Per-protocol analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Oxygen Requirement (Per-protocol Analysis)</title>
          <description>The total duration of oxygen therapy (Per-protocol analysis).</description>
          <population>Per-protocol analysis.</population>
          <units>hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.0" lower_limit="12.0" upper_limit="38.5"/>
                    <measurement group_id="O2" value="18.5" lower_limit="4.0" upper_limit="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay (Intention-to-treat Analysis)</title>
        <description>The time from randomization to the patient's discharge (Intention-to-treat analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay (Intention-to-treat Analysis)</title>
          <description>The time from randomization to the patient's discharge (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis.</population>
          <units>day</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" lower_limit="4.0" upper_limit="7.7"/>
                    <measurement group_id="O2" value="5.0" lower_limit="4.0" upper_limit="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.22</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay (Per-protocol Analysis)</title>
        <description>The time from randomization to the patient's discharge (Per-protocol analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Per-protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay (Per-protocol Analysis)</title>
          <description>The time from randomization to the patient's discharge (Per-protocol analysis).</description>
          <population>Per-protocol analysis</population>
          <units>day</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="4" upper_limit="6"/>
                    <measurement group_id="O2" value="5" lower_limit="4" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Failure at 4 Hours (Intention-to-treat Analysis)</title>
        <description>The number of treatment failures at 4 hours in each study arm (Intention-to-treat analysis).</description>
        <time_frame>4 hours</time_frame>
        <population>The population of the intention to treat.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Failure at 4 Hours (Intention-to-treat Analysis)</title>
          <description>The number of treatment failures at 4 hours in each study arm (Intention-to-treat analysis).</description>
          <population>The population of the intention to treat.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pediatric Intensive Care Unit Admission (Intention-to-treat Analysis).</title>
        <description>The number of participants admitted to the intensive care unit for invasive mechanical ventilation (Intention-to-treat analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Pediatric Intensive Care Unit Admission (Intention-to-treat Analysis).</title>
          <description>The number of participants admitted to the intensive care unit for invasive mechanical ventilation (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events of Therapy (Intention-to-treat Analysis)</title>
        <description>The number of participants with any adverse events in therapy groups (Intention-to-treat analysis).</description>
        <time_frame>through study completion, an average of 168 hours</time_frame>
        <population>Intention to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>St-FMOT</title>
            <description>Children who received Standard Face Mask Oxygen Therapy</description>
          </group>
          <group group_id="O2">
            <title>HFNCOT</title>
            <description>Children who received High-Flow Nasal Cannula Oxygen Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events of Therapy (Intention-to-treat Analysis)</title>
          <description>The number of participants with any adverse events in therapy groups (Intention-to-treat analysis).</description>
          <population>Intention to treat analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.08</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected for 6 weeks.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Active Comparator: High-Flow Nasal Cannula Oxygen Therapy</title>
          <description>Children in the high-flow group received heated and humidified high-flow oxygen at a rate of 2 L*kg/min (maximum 25 L/min), using an age-appropriate Optiflow Junior cannula and Airvo 2 high-flow system (Fisher and Paykel Healthcare). The initial fraction of inspired oxygen (FiO2) was set at 40%. The starting flow rate continued for a minimum of 4 hours. According to the patients' clinical response, the flow rate was decreased by 0.5 L*kg/min per hour. The FiO2 was adjusted to obtain the oxygen saturation levels between 92-98%. When the flow rate was at 0.5 L*kg/min, and the FiO2 was equal to the ambient oxygen concentration, High-Flow nasal cannula oxygen therapy was stopped.</description>
        </group>
        <group group_id="E2">
          <title>Active Comparator: Standard Face Mask Oxygen Therapy</title>
          <description>Children in the standard-therapy group received supplemental oxygen via a simple face mask, a range of 6-10 L/min, to maintain the oxygen saturation level between 92-98%. Those who sustained the oxygen saturation &gt;92% in the ambient oxygen concentration were weaned off Standard Face Mask Oxygen Therapy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Transient bradicardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was performed in a single center and had a limited sample size. We did not blind the allocation of oxygen therapies to introduce the risk of performance bias.&#xD;
We did not reach the number of participants calculated with the power analysis because of the financial support problem. Therefore, we used effect size for each of the primary outcomes.&#xD;
Patients were not allocated to receive therapy in a ratio of 1:1. Hence, a numerical difference occurred between the two groups.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Aykut Eşki</name_or_title>
      <organization>Ege University Medical Faculty Hospital</organization>
      <phone>05303009760</phone>
      <email>aykuteski1984@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

